返回
Abbisko Cayman Limited（02256.HK）價格
02256.HK 股價走勢圖
ABBISKO-B (02256.HK)
Abbisko Cayman Limited
HK$14.5
1.68%
$0.24
休市： Jan 16, 16:00:00 HKT
關鍵數據
前收市價
$14.73
開盤價
$14.26
當日範圍
$14.25 - $14.69
52週區間
$4.2 - $19.78
交易量
658.0K
平均成交量
2.4M
每股盈餘 (TTM)
0.26
股息收益率
--
市值
$9.5B
什麼是 ABBISKO-B？
Abbisko Cayman Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of drugs and small molecule oncology therapies. The company is headquartered in Shanghai, Shanghai and currently employs 226 full-time employees. The company went IPO on 2021-10-13. The firm is dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The firm owns two Core Product Candidates, ABSK011 and ABSK091, and 12 other pipeline product candidates. ABSK011 is a potent and highly selective small molecule inhibitor of fibroblast growth factor receptor 4 (FGFR4). ABSK091 is a molecularly targeted product candidate and a highly potent and selective inhibitor of FGFR subtypes 1, 2 and 3. The Company’s products are primarily being developed for hepatocellular carcinoma (HCC), urothelial cancer (UC) and gastric cancer (GC).
